News + Filings Transactions Holdings
All 13F 13D/G Other
|
Kinnevik AB (publ)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/06/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
07/25/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
04/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/01/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
12/30/2022 |
3
| Kinnevik AB (publ) (10% Owner) has filed a Form 3 on Babylon Holdings Ltd |
10/25/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/08/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/25/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
05/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/08/2022 |
SC 13G
| Invik S.A. reports a 16.6% stake in Babylon Holdings Limited |
04/15/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/21/2020 |
SC 13D/A
| Kinnevik AB reports a 5.2% stake in Teladoc Health, Inc. |
11/09/2020 |
SC 13D
| Kinnevik AB reports a 5.2% stake in Teladoc Health, Inc. |
11/03/2020 |
SC 13D/A
| Kinnevik AB reports a 0% stake in Livongo Health, Inc. |
01/21/2020 |
SC 13G/A
| Kinnevik AB reports a 0% stake in MILLICOM INTERNATIONAL CELLULAR S.A. |
07/31/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
07/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/24/2019 |
3
| Kinnevik AB (publ) (10% Owner) has filed a Form 3 on Livongo Health, Inc. |
02/01/2019 |
SC 13G
| Kinnevik AB reports a 37.2% stake in MILLICOM INTERNATIONAL CELLULAR S.A. |
|
|